三元生物：股东鲁信资本减持近600万股，持股降至0.97%

Core Viewpoint - The announcement from San Yuan Bio indicates that shareholder Luxin Capital has completed its share reduction plan, which involved a total reduction of approximately 599,005 shares, representing about 2.995% of the total share capital [1] Summary by Sections Shareholder Reduction Plan - Luxin Capital originally planned to reduce its holdings by up to 6 million shares, or 3% of the total share capital, starting from a specific date in 2025 [1] - As of the announcement date, Luxin Capital executed the reduction between August 7 and October 29, 2025, through block trades and centralized bidding [1] Reduction Details - The total shares reduced included 400,000 shares through block trades and 199,005 shares through centralized bidding, culminating in a total of 599,005 shares [1] - Following the reduction, Luxin Capital's holdings decreased to 193,000 shares, which is 0.97% of the total share capital [1] Impact on Company - The share reduction did not result in a change of control for the company and is not expected to have a significant impact on its operations [1]